INDIVA Common Shares Added to the HMMJ ETF

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./

LONDON, ON, Sept. 26, 2018 /CNW/ - INDIVA Limited (the "Company" or "INDIVA") (TSXV: NDVA) is pleased to announce that it has been included in the Horizons Marijuana Life Sciences exchange-traded fund (TSX: HMMJ).  The HMMJ is a fund that provides investors with a basket of North American publicly listed businesses active in the marijuana industry.

"Investors that prefer a more diversified portfolio and would like to own INDIVA will now be able to do so through HMMJ. We see this development further improving the liquidity of our shares which is a positive development for all INDIVA shareholders," announced Niel Marotta, CEO.

About INDIVA
INDIVA's wholly owned subsidiary is a Licensed Producer under Canada's Access to Cannabis for Medical Purposes Regulation ("ACMPR").

INDIVA's mission is to offer cannabis products that have a positive impact, improving lives and communities.   

DISCLAIMER & READER ADVISORY
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) has in any way passed upon the merits of the Transaction and neither of the foregoing entities accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.

Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties' current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the Company's inclusion in HMMJ. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to Indiva. The material factors and assumptions include Indiva being able to obtain necessary corporate, regulatory and other third-party approvals. The forward looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking information. The foregoing statements expressly qualify any forward-looking information contained herein.

This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.

SOURCE Indiva Limited

Niel Marotta, CEO, INDIVA, Phone: [phone], Email: [email protected]; Steve Low, Investor Relations, Phone: [phone], Email: [email protected]